Araştırma Makalesi
BibTex RIS Kaynak Göster

PARKİNSON HASTALARININ İŞ BIRAKMA NEDENLERİNİN İNCELENMESİ

Yıl 2022, Cilt: 33 Sayı: 2, 98 - 105, 20.08.2022

Gamze Ertürk , Semra Oğuz , Mine Gülden Polat , Sibel Ertan

https://doi.org/10.21653/tjpr.1002094

Öz

Amaç: Parkinson hastalarındaki erken emeklilik oranının giderek arttığı bilinmektedir. Bu hasta popülasyonunda erken emekliliğe neden olan faktörler arasında kısıtlı sayıda veri vardır. Çalışmadaki amacımız Parkinson hastalığının erken emekliliğe neden olan etkilerini incelemektir.
Yöntem: Çalışmaya 75 Parkinson hastası (ortalama yaş: 59,10±9,20 yıl) dâhil edildi. Literatür ve benzer çalışmalar incelenerek araştırmacılar tarafından belirlenen 29 soru çerçevesinde hastalar ile yüz yüze görüşülerek veri toplandı.
Sonuçlar: Katılımcılar emeklilik türlerine ve emekli olma nedenlerine göre iki farklı şekilde gruplanarak incelendi. Parkinson hastalığı nedeniyle işten ayrılan hastalar tarafından motor semptomlar içinde bradikinezi, non-motor semptomlar içerisinde ise uyku bozukluğu ve depresyon emeklilik nedeni olarak ilk sırada gösterildi. Parkinson hastalığı nedeniyle işten ayrılan katılımcıların %90’ının çalıştıkları kurum tarafından desteklenmediği; %77,55’inin fizyoterapi tedavisi, %61,22’sinin ise psikolojik tedavi almadığı belirlendi. Ayrıca katılımcıların %55,10’inin uygun bir iş bulması halinde çalışmak istediği belirlendi.
Tartışma: Hastaların iş hayatını daha uzun süre devam ettirebilmeleri için Parkinson hastalarının, bakım verenlerinin ve işverenlerinin Parkinson hastalığı ile ilgili sağlık sorunları, bunların olası sonuçları, ayrıca motor ve non-motor semptomlara yönelik geliştirilen stratejiler ve tedavi teknikleri hakkında bilgilendirilmeleri gerekmektedir.

Anahtar Kelimeler

erken emeklilik işten ayrılma motor semptomlar non-motor semptomlar Parkinson hastalığı

Kaynakça

  • 1. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72(21 Suppl 4): S1-136.
  • 2. Grosset DG, Macphee GJ, Nairn M, Guideline Development G. Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. BMJ. 2010;340: b5614.
  • 3. Gershanik OS. Clinical problems in late-stage Parkinson's disease. J Neurol. 2010;257(Suppl 2): S288-91.
  • 4. Wickremaratchi MM, Perera D, O'Loghlen C, Sastry D, Morgan E, Jones A, et al. Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry. 2009;80(7):805-7.
  • 5. Martikainen KK, Luukkaala TH, Marttila RJ. Parkinson's disease and working capacity. Mov Disord. 2006;21(12):2187-91.
  • 6. Koerts J, Konig M, Tucha L, Tucha O. Working capacity of patients with Parkinson's disease - A systematic review. Parkinsonism Relat Disord. 2016; 27:9-24.
  • 7. Schrag A, Banks P. Time of loss of employment in Parkinson's disease. Mov Disord. 2006;21(11):1839-43.
  • 8. Murphy R, Tubridy N, Kevelighan H, O'Riordan S. Parkinson's disease: how is employment affected? Ir J Med Sci. 2013;182(3):415-9.
  • 9. Zesiewicz TA, Patel-Larson A, Hauser RA, Sullivan KL. Social Security Disability Insurance (SSDI) in Parkinson's disease. Disabil Rehabil. 2007;29(24):1934-6.
  • 10. Clarke CE, Patel S, Ives N, Rick CE, Woolley R, Wheatley K, et al. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB). Health Technol Asses. 2016;20(63):1-96.
  • 11. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1998;50(2): B1-B16.
  • 12. von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, et al. Costs of illness and care in Parkinson's disease: an evaluation in six countries. Eur Neuropsychopharmacol. 2011;21(2):180-91.
  • 13. Abeynayake I, Tanner CM. The economic impact of OFF periods in Parkinson disease. Am J Manag Care. 2020;26(12): 265-69.
  • 14. Murphy MJ, Peterson MJ. Sleep Disturbances in Depression. Sleep Med Clin. 2015;10(1):17-23.
  • 15. Kim JW, Kwon Y, Kim YM, Chung HY, Eom GM, Jun JH, et al. Analysis of lower limb bradykinesia in Parkinson's disease patients. Geriatr Gerontol Int. 2012;12(2):257-64.
  • 16. Marsh L. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep. 2013;13(12):409.
  • 17. Kay DB, Tanner JJ, Bowers D. Sleep disturbances and depression severity in patients with Parkinson's disease. Brain Behav. 2018;8(6): e00967.
  • 18. Mamatoğlu N. Türkiye’de Engelli İstihdamının Genel Görünümü: İşveren Gözüyle Engelli İstihdamını Arttırma Konusunda Önerilen Politikalar. Altern Polit. 2015; 7:524–58.

INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON'S PATIENTS

Yıl 2022, Cilt: 33 Sayı: 2, 98 - 105, 20.08.2022

Gamze Ertürk , Semra Oğuz , Mine Gülden Polat , Sibel Ertan

https://doi.org/10.21653/tjpr.1002094

Öz

Purpose: It is known that early retirement has been increasing for patients with Parkinson's disease. The data on the factors that cause early retirement in this patient population is limited. The objective of this study is to analyze the effects of Parkinson's disease that cause early retirement.
Methods: Seventy-five patients with Parkinson’s disease (mean age: 59.10±9.20 years) participated in this study. Data were collected through face-to-face interviews with patients within the framework of 29 questions determined by the researchers by examining the literature and similar studies.
Results: Participants have been analyzed into groups: Retirement types and reasons for retirement. Patients that quit their jobs because of Parkinson's disease stated that bradykinesia in motor symptoms, somnipathy, and depression in non-motor symptoms came first in their reasons for retirement. It has been determined that 90% of participants that quit their jobs because of Parkinson's disease were not supported by the institutions they worked for, 77.55% couldn't receive physiotherapy treatment and 61.22% couldn't receive psychological therapy. In addition, it has been determined that 55.1% of the participants would like to work if they find a suitable job.
Conclusion: For patients to stay in the workforce longer, patients with Parkinson's disease, their caregivers, and employers should be informed about the health problems associated with Parkinson's disease, their possible consequences, as well as strategies and treatment techniques developed for motor and non motor symptoms.

Anahtar Kelimeler

early-retirement Employee turnover motor symptoms non-motor symptoms Parkinson's disease

Kaynakça

  • 1. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72(21 Suppl 4): S1-136.
  • 2. Grosset DG, Macphee GJ, Nairn M, Guideline Development G. Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. BMJ. 2010;340: b5614.
  • 3. Gershanik OS. Clinical problems in late-stage Parkinson's disease. J Neurol. 2010;257(Suppl 2): S288-91.
  • 4. Wickremaratchi MM, Perera D, O'Loghlen C, Sastry D, Morgan E, Jones A, et al. Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry. 2009;80(7):805-7.
  • 5. Martikainen KK, Luukkaala TH, Marttila RJ. Parkinson's disease and working capacity. Mov Disord. 2006;21(12):2187-91.
  • 6. Koerts J, Konig M, Tucha L, Tucha O. Working capacity of patients with Parkinson's disease - A systematic review. Parkinsonism Relat Disord. 2016; 27:9-24.
  • 7. Schrag A, Banks P. Time of loss of employment in Parkinson's disease. Mov Disord. 2006;21(11):1839-43.
  • 8. Murphy R, Tubridy N, Kevelighan H, O'Riordan S. Parkinson's disease: how is employment affected? Ir J Med Sci. 2013;182(3):415-9.
  • 9. Zesiewicz TA, Patel-Larson A, Hauser RA, Sullivan KL. Social Security Disability Insurance (SSDI) in Parkinson's disease. Disabil Rehabil. 2007;29(24):1934-6.
  • 10. Clarke CE, Patel S, Ives N, Rick CE, Woolley R, Wheatley K, et al. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB). Health Technol Asses. 2016;20(63):1-96.
  • 11. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1998;50(2): B1-B16.
  • 12. von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, et al. Costs of illness and care in Parkinson's disease: an evaluation in six countries. Eur Neuropsychopharmacol. 2011;21(2):180-91.
  • 13. Abeynayake I, Tanner CM. The economic impact of OFF periods in Parkinson disease. Am J Manag Care. 2020;26(12): 265-69.
  • 14. Murphy MJ, Peterson MJ. Sleep Disturbances in Depression. Sleep Med Clin. 2015;10(1):17-23.
  • 15. Kim JW, Kwon Y, Kim YM, Chung HY, Eom GM, Jun JH, et al. Analysis of lower limb bradykinesia in Parkinson's disease patients. Geriatr Gerontol Int. 2012;12(2):257-64.
  • 16. Marsh L. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep. 2013;13(12):409.
  • 17. Kay DB, Tanner JJ, Bowers D. Sleep disturbances and depression severity in patients with Parkinson's disease. Brain Behav. 2018;8(6): e00967.
  • 18. Mamatoğlu N. Türkiye’de Engelli İstihdamının Genel Görünümü: İşveren Gözüyle Engelli İstihdamını Arttırma Konusunda Önerilen Politikalar. Altern Polit. 2015; 7:524–58.
Toplam 18 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Araştırma Makaleleri
Yazarlar

Gamze Ertürk 0000-0002-5038-9005

Semra Oğuz 0000-0002-7148-4562

Mine Gülden Polat 0000-0002-9705-9740

Sibel Ertan Bu kişi benim 0000-0003-1339-243X

Yayımlanma Tarihi 20 Ağustos 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 33 Sayı: 2

Kaynak Göster

APA Ertürk, G., Oğuz, S., Polat, M. G., Ertan, S. (2022). INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS. Türk Fizyoterapi Ve Rehabilitasyon Dergisi, 33(2), 98-105. https://doi.org/10.21653/tjpr.1002094
AMA Ertürk G, Oğuz S, Polat MG, Ertan S. INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS. Turk J Physiother Rehabil. Ağustos 2022;33(2):98-105. doi:10.21653/tjpr.1002094
Chicago Ertürk, Gamze, Semra Oğuz, Mine Gülden Polat, ve Sibel Ertan. “INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS”. Türk Fizyoterapi Ve Rehabilitasyon Dergisi 33, sy. 2 (Ağustos 2022): 98-105. https://doi.org/10.21653/tjpr.1002094.
EndNote Ertürk G, Oğuz S, Polat MG, Ertan S (01 Ağustos 2022) INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS. Türk Fizyoterapi ve Rehabilitasyon Dergisi 33 2 98–105.
IEEE G. Ertürk, S. Oğuz, M. G. Polat, ve S. Ertan, “INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS”, Turk J Physiother Rehabil, c. 33, sy. 2, ss. 98–105, 2022, doi: 10.21653/tjpr.1002094.
ISNAD Ertürk, Gamze vd. “INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS”. Türk Fizyoterapi ve Rehabilitasyon Dergisi 33/2 (Ağustos 2022), 98-105. https://doi.org/10.21653/tjpr.1002094.
JAMA Ertürk G, Oğuz S, Polat MG, Ertan S. INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS. Turk J Physiother Rehabil. 2022;33:98–105.
MLA Ertürk, Gamze vd. “INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS”. Türk Fizyoterapi Ve Rehabilitasyon Dergisi, c. 33, sy. 2, 2022, ss. 98-105, doi:10.21653/tjpr.1002094.
Vancouver Ertürk G, Oğuz S, Polat MG, Ertan S. INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON’S PATIENTS. Turk J Physiother Rehabil. 2022;33(2):98-105.
 Kapak Resmi İndir